Abstract
Video-assisted mediastinal lymphadenectomy (VAMLA) has been introduced into our clinical practice as a surgical method for N-staging of non-small cell lung cancer (NSCLC) since 2017. In this paper, we presented the technique of VAMLA, analyzed our experience and compared the re- sults of the intervention with previously published data from other authors. Material and methods. The study ncluded materials from the examination and treatment of 56 patients with NSCLC who underwent VAMLA as part of the preoperative determination of the N-stage. Results. The average intervention time was 113±25 minutes. Each patient had 18.7±7.3; Me=18 (14–24) lymph nodes re- moved, from an average of 4.3±0.7 stations. The lymph nodes of groups 2R, 4R, 2L, 4L, and 7 were removed in 93, 100, 24, 100, and 100%, respectively. Biopsy of availa- ble nodes of group 10R was performed in 19.6% (11/56). 7 patients (12.5%) developed dysphonia after surgery. The learning curve of the new method in our experience was 30 operations. After VAMLA there were no missed me- tastases in the accessible areas of the mediastinum. Conclusion. VAMLA is an effective and safe therapeutic and diagnostic intervention that demonstrates a consistently high volume of bilateral mediastinal lymphadenectomy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
